GL OB
AL &
RO UT
IN E
TE ST
S FI
BR IN
OL YS
IS TH
RO M
BO PH
IL IA
RE SE
AR CH
PR IM
AR Y
HE M
OS TA
SI S
CA LI
BR AT
OR S
& CO
NT RO
LS IN
DE X
M ON
IT OR
IN G
AN TI
CO AG
UL AN
T AU
XI LI
AR Y
RE AG
EN TS
BL EE
DI NG
DI
SO RD
ER S
33 32
FACTOR XIII (FXIII) (2)
Autosomal recessive inheritance. Umbilical cord bleeding is common in FXIII deficiency. Some patients sustain a spontaneous intracranial hemorrhage, a brain bleed, which is the leading
cause of mortality. Other symptoms of FXIII deficiency include bruising, nose and mouth bleeds, muscle bleeds and delayed bleeding after surgery.
Women can experience menorrhagia, long, heavy menstrual periods, and repeat miscarriages. Men with FXIII deficiency may show signs of infertility. Acquired FXIII deficiency can be observed in presence of autoantibodies.
BIOPHEN™ Factor XIII Determination of FXIII activity in human citrated plasma. Reagent and material required: automatic instrument for chromogenic assays with a wavelength
at 340 nm.
REAGENT Product Name RS Ref. Presentation
BIOPHEN™ Factor XIII CE-IVD 227005
R1: 3 x 4 mL
R2: 3 x 5 mL
Research
Factor XIII Deficient Plasma For any study or research protocol where a source of human FXIII deficient plasma is required.
REAGENT Product Name RS Ref. Presentation Factor XIII
Deficient Plasma
RUO DP200K 6 x 1 mL
Research
ZYMUTEST™ Factor XIII-A Measurement of FXIII (subunit A) in human plasma, or in any biological medium where Factor XIII (FXIII) is present, by Elisa.
COMPLETE SOLUTION Product Name RS Ref. Presentation
ZYMUTEST™ Factor XIII-A RUO
RK034A on demand
96 tests
FACTOR II (FII) / PROTHROMBIN (1,2,3)
Autosomal recessive inheritance. Prothrombin deficiency is a rare hereditary coagulation disorder. Symptoms include excessive umbilical cord bleeding, easy bruising, frequent nosebleeds and
hemorrhaging after surgery or trauma. Women with FII deficiency experience menorrhagia, heavy menstrual bleeding, and postpartum hemorrhage after childbirth.
Dysprothrombinemia results from a protein abnormality, which affects prothrombin clotting activity. Hypoprothrombinemia occurs when prothrombin concentration is decreased.
Factor II Deficient Plasma Used in combination with CEPHEN™ (ref. CK511K CK512K CK515K CK515L) to measure FXI clotting activity in human citrated plasma.
REAGENT CALIBRATOR CONTROLS Product Name RS Ref. Presentation Product Name Ref. Product Name Ref.
Prothrombin Deficient Plasma
CE-IVD DP010A 1 x 1 mL BIOPHEN™
Plasma Calibrator
222101
BIOPHEN™ Normal Control Plasma
BIOPHEN™ Abnormal Control Plasma
223201
223301 DP010K 6 x 1 mL
FACTOR V (FV) (1)
Autosomal recessive inheritance. FV is deficient in presence of congenital or acquired FV deficiencies, hepatic disorders or
accelerated clotting factor consumption (DIC). High levels of FV are risk factors for venous thrombosis.
Factor V Deficient Plasma Used in combination with PT-Phen™ (ref. CK581 - CK582 - CK583 - CK584K - CK584L - CK586K - CK586L) to measure FV or Proaccelerin activity in human citrated plasma.
REAGENT CALIBRATOR CONTROLS Product Name RS Ref. Presentation Product Name Ref. Product Name Ref.
Factor V Deficient Plasma
CE-IVD DP020A 1 x 1 mL BIOPHEN™
Plasma Calibrator
222101
BIOPHEN™ Normal Control Plasma
BIOPHEN™ Abnormal Control Plasma
223201
223301 DP020K 6 x 1 mL
Research
ZYMUTEST™ Factor V Measurement of human FV antigen in plasma, or in any fluid where Factor V can be present, by Elisa.
COMPLETE SOLUTION Product Name RS Ref. Presentation
ZYMUTEST™ Factor V RUO
RK009A on- demand
96 tests
(1) cf Dedicated intructions for use - (2) www.afh.asso.fr - (3) www.hemophilia.org (2) www.hemophilia.org